SG11201609382WA - Compositions and methods for stabilizing luminogenic substrates - Google Patents
Compositions and methods for stabilizing luminogenic substratesInfo
- Publication number
- SG11201609382WA SG11201609382WA SG11201609382WA SG11201609382WA SG11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA SG 11201609382W A SG11201609382W A SG 11201609382WA
- Authority
- SG
- Singapore
- Prior art keywords
- stabilizing
- compositions
- methods
- luminogenic substrates
- luminogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
- C09K11/06—Luminescent materials, e.g. electroluminescent or chemiluminescent containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Electroluminescent Light Sources (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462002363P | 2014-05-23 | 2014-05-23 | |
| PCT/US2015/032439 WO2015179864A1 (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201609382WA true SG11201609382WA (en) | 2016-12-29 |
Family
ID=53434457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201609382WA SG11201609382WA (en) | 2014-05-23 | 2015-05-26 | Compositions and methods for stabilizing luminogenic substrates |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9676997B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3146066B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6641297B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102456212B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106661028B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015263901B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016027504B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2949447C (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201609382WA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015179864A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3661932B1 (en) | 2017-08-04 | 2021-10-06 | Promega Corporation | Compositions and methods for stabilizing benzothiazole luciferin analogs |
| IL318819A (en) | 2018-10-03 | 2025-04-01 | Promega Corp | Compounds and methods for stabilizing cholinetyrazine and its derivatives |
| CN111116594B (zh) * | 2019-12-03 | 2021-05-28 | 山东大学 | 一种C-6位改造NanoLuc类型类似物及其制备方法与应用 |
| CN121399275A (zh) * | 2024-05-21 | 2026-01-23 | 深圳琅技生命科技有限公司 | 用于稳定腔肠素及其类似物的组合物及方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2000622A1 (de) * | 1970-01-08 | 1971-07-22 | Agfa Gevaert Ag | Verfahren zur Stabilisierung von Silberbildern |
| JP4639904B2 (ja) * | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP4761150B2 (ja) * | 2006-07-24 | 2011-08-31 | 独立行政法人産業技術総合研究所 | ハイスループット発光活性測定のためのセレンテラジン(ウミシイタケルシフェリン)溶液の安定化組成物および安定化法 |
| US7718389B2 (en) * | 2006-07-24 | 2010-05-18 | National Institute Of Advanced Industrial Science And Technology | Stabilizing composition and stabilizing method of coelenterazine solution for high-throughput measurement of luciferase activity |
| EP2626703B1 (en) * | 2008-03-27 | 2017-05-03 | Promega Corporation | Protein labeling with cyanobenzothiazole conjugates |
| CN103443121B (zh) | 2010-11-02 | 2016-04-20 | 普罗梅加公司 | 新型腔肠素底物及其使用方法 |
-
2015
- 2015-05-26 EP EP15730321.5A patent/EP3146066B1/en active Active
- 2015-05-26 CN CN201580026864.3A patent/CN106661028B/zh active Active
- 2015-05-26 KR KR1020167033229A patent/KR102456212B1/ko active Active
- 2015-05-26 CA CA2949447A patent/CA2949447C/en active Active
- 2015-05-26 SG SG11201609382WA patent/SG11201609382WA/en unknown
- 2015-05-26 JP JP2016569444A patent/JP6641297B2/ja active Active
- 2015-05-26 US US14/721,727 patent/US9676997B2/en active Active
- 2015-05-26 WO PCT/US2015/032439 patent/WO2015179864A1/en not_active Ceased
- 2015-05-26 BR BR112016027504-7A patent/BR112016027504B1/pt active IP Right Grant
- 2015-05-26 AU AU2015263901A patent/AU2015263901B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3146066B1 (en) | 2018-03-14 |
| WO2015179864A1 (en) | 2015-11-26 |
| BR112016027504A2 (cg-RX-API-DMAC7.html) | 2017-08-15 |
| AU2015263901A1 (en) | 2016-11-24 |
| JP2017519977A (ja) | 2017-07-20 |
| KR102456212B1 (ko) | 2022-10-20 |
| US20150337198A1 (en) | 2015-11-26 |
| BR112016027504B1 (pt) | 2023-04-18 |
| CN106661028B (zh) | 2021-08-06 |
| US9676997B2 (en) | 2017-06-13 |
| CA2949447A1 (en) | 2015-11-26 |
| EP3146066A1 (en) | 2017-03-29 |
| AU2015263901B2 (en) | 2021-03-11 |
| JP6641297B2 (ja) | 2020-02-05 |
| CA2949447C (en) | 2022-10-04 |
| CN106661028A (zh) | 2017-05-10 |
| KR20170012271A (ko) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285565B (en) | Methods and preparations for immune modulation | |
| SG10202109655VA (en) | Compositions and methods for immunooncology | |
| GB2535253B (en) | Compositions and methods | |
| GB2546350B (en) | Compositions and methods | |
| IL249648A0 (en) | Carrier-antibody preparations and methods for their preparation and use | |
| IL249446A0 (en) | Preparations and methods for production packaging | |
| GB201718876D0 (en) | Antithrombin-heparin compositions and methods | |
| IL247614B (en) | Methods and preparations for changing the immune response | |
| IL246879A0 (en) | Preparations of Epilimod and methods of using them | |
| GB201417828D0 (en) | New methods and compositions | |
| IL252738A0 (en) | Carrier molecule preparations and related methods | |
| PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
| SG11201701402QA (en) | Anti-tumor compositions and methods | |
| EP3097420A4 (en) | Methods and compositions for immune dis-inhibition | |
| ZA201703123B (en) | Combination long acting compositions and methods for hepatitis c | |
| IL248513A0 (en) | Preparations and methods for immunomodulation against lyst | |
| GB201512996D0 (en) | Compositions and methods | |
| PT3160263T (pt) | Composições para prevenção de infeções | |
| EP3221366A4 (en) | Polyaminomethylbenzyloxalamides and compositions and methods related thereto | |
| PT3210628T (pt) | Métodos para complexos de frutoborato | |
| PL2990058T3 (pl) | Ulepszone kompozycje i sposoby dla kompleksów fruktoboranowych | |
| GB201514413D0 (en) | Compositions and methods | |
| GB201402915D0 (en) | Compositions and methods | |
| IL249103A0 (en) | Compositions and methods for stabilizing luminogenic substrates | |
| IL256261B (en) | Hide1 compositions and methods |